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Abstract
Introduction: Mammographic density, a strong predictor for breast cancer incidence, may also worsen prognosis
in women with breast cancer. This prospective analysis explored the effect of prediagnostic mammographic
density among 607 breast cancer cases diagnosed within the Hawaii component of the Multiethnic Cohort (MEC).
Methods: Female MEC participants, aged ≥ 50 years at cohort entry, diagnosed with primary invasive breast
cancer, and enrolled in a mammographic density case-control study were part of this analysis. At cohort entry,
anthropometric and demographic information was collected by questionnaire. Tumor characteristics and vital
status were available through linkage with the Hawaii Tumor Registry. Multiple digitized prediagnostic
mammograms were assessed for mammographic density using a computer-assisted method. Cox proportional
hazards regression was applied to examine the effect of mammographic density on breast cancer survival while
adjusting for relevant covariates.
Results: Of the 607 cases, 125 were diagnosed as in situ, 380 as localized, and 100 as regional/distant stage. After
a mean follow-up time of 12.9 years, 27 deaths from breast cancer and 100 deaths from other causes had
occurred; 71 second breast cancer primaries were diagnosed. In an overall model, mammographic density was not
associated with breast cancer-specific survival (HR = 0.95 per 10%; 95%CI: 0.79-1.15), but the interaction with
radiotherapy was highly significant (p = 0.006). In stratified models, percent density was associated with a reduced
risk of dying from breast cancer (HR = 0.77; 95%CI: 0.60-0.99; p = 0.04) in women who had received radiation, but
with an elevated risk (HR = 1.46; 95% CI: 1.00-2.14; p = 0.05) in patients who had not received radiation. High
breast density predicted a borderline increase in risk for a second primary (HR = 1.72; 95% CI: 0.88-2.55; p = 0.15).
Conclusions: Assessing mammographic density in women with breast cancer may identify women with a poorer
prognosis and provide them with radiotherapy to improve outcomes.
Introduction
Mammographic density - the distribution of fat, connec-
tive, and epithelial tissue in the breast - has been used as
a biomarker because a high percentage of dense parench-
yma on mammographic images confers a four- to six-
fold risk for breast cancer [1], but its relation to breast
cancer survival has been much less studied. The histo-
pathologic correlates of mammographic density are
thought to represent dense connective tissues in addition
to epithelial cells [2], but the amount of connective tissue
is far greater (approximately 11-fold) than glandular
tissue and contributes more to the variability in percen-
tage of dense area [3-6]. It appears that the extracellular
matrix (ECM) contributes to neoplastic progression and
that disruptions in the ECM may precede epithelial
changes [7]. Therefore, collagen-dense stroma associated
with mammographic density may enhance tumor forma-
tion through epithelial-stromal interactions [8,9] and
increase the likelihood for regrowth and progression [10].
Moreover, higher mammographic density may increase
the probability of malignant initiation by representing a
larger number of cells at risk that may proceed to neopla-
sia within the collagen-dense microenvironment [11].
So far, six reports have examined the influence of
mammographic density on breast cancer outcomes: three
on recurrence [12-14] and three on survival [15-17]. One
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study reported a higher risk of invasive breast cancer
among ductal carcinoma in situ (DCIS) patients with
highly dense breasts [12], and two investigations found
higher local recurrence rates with higher density [13,14].
Three mammography cohorts using qualitative mammo-
graphic density assessment methods investigated breast
density as a predictor of breast cancer-specific survival.
An inverse association that was borderline significant was
detected in a Swedish cohort [16], but no adverse effect
of mammographic density on survival was found in a
British [15] or a US [17] cohort. Based on the hypothesis
that prediagnostic breast density adversely affects breast
cancer outcomes, this analysis examined mammographic
density as a predictor of breast cancer-specific survival
after adjusting for important prognostic factors within
the Hawaii component of the Multiethnic Cohort (MEC).
Materials and methods
Study population
A nested case-control study [18] within the MEC is the
basis for the present analysis and was established in
1993-1996 to study diet and other exposures in relation
to cancer among different ethnic groups in Hawaii and
California [19]. The original cohort and the nested case-
control study were approved by the Committee on
Human Studies at the University of Hawaii. All subjects
signed an informed consent form to participate in the
study and a release form to allow the retrieval of mam-
mograms. Subjects entered the cohort by completing a
26-page, self-administered mailed survey that asked
about demographics, anthropometric measures, diet,
lifestyle factors, and the presence of major co-morbid-
ities (for example, diabetes, hypertension, and heart dis-
ease). Owing to logistic problems in retrieving
mammograms in California, the mammographic density
investigation was restricted to Hawaii [18]. For the
nested case-control study, 1,587 potential cases were
identified, 734 cases agreed to participate, and for 607
women mammograms could be obtained. Despite the
relatively low participation rate, the included women
were similar to the eligible subjects [18]. Linkage with
the Hawaii Tumor Registry (HTR), part of the Surveil-
lance, Epidemiology, and End Results (SEER) program,
provided the most recent vital status, last date of con-
tact, cause of death, and tumor characteristics, including
stage at diagnosis and treatment during the first 6
months. Based on the primary cause of death, deaths
were classified as those from breast cancer and those
from other causes. Cancer recurrence information is not
routinely collected by the HTR. Second breast cancers
were identified according to SEER coding rules [20];
tumors in the contralateral breast and ipsilateral cancers
diagnosed more than 5 years apart are considered multi-
ple primaries.
Mammographic density assessment
As described previously, multiple mammographic films
were obtained for each woman to cover a wide time
period; cases had a mean of 3.2 density measures [18].
The values for the right and the left breast and for the
repeated density measures were averaged. The mean
time between the earliest mammogram and the breast
cancer diagnosis was 6.3 years, whereas the earliest and
the latest mammogram were 5.1 years apart. Except for
the film of five cases who only had a mammogram of
the healthy breast taken at the time of diagnosis, all
images were prediagnostic. The mammographic films
from both breasts were scanned with a Kodak LS85
Film Digitizer (Eastman Kodak Company, Rochester,
NY, USA) at a resolution of 98 pixels per inch. One of
the authors (GM) performed computer-assisted density
assessment by using Cumulus software [21] with excel-
lent quality control results. In a random sample of 410
mammograms read in duplicate [18], the intraclass cor-
relation coefficients were 0.96 (95% confidence interval
(CI) 0.95 to 0.97) for the size of the dense areas and
0.974 for percent density (95% CI 0.968 to 0.978).
Statistical analysis
We used the SAS package, release 9.3 (SAS Institute Inc.,
Cary, NC, USA) for all analyses. Follow-up time was calcu-
lated from the date of diagnosis until the earliest event of
interest (that is, death, second breast cancer diagnosis, the
last date of contact, or 1 August 2011). We used three
approaches to examine percent density: as a continuous
variable rescaled and expressed per 10% increase, as a
dichotomous variable classified into low and high by using
the median of 35%, and as three categories (less than 25%,
25 to less than 50%, or at least 50%). Body mass index
(BMI) was categorized as normal, overweight, or obese.
Because of the small number of events, hormone receptor
status was classified as a two-level variable: (a) estrogen
receptor-positive/progesterone receptor-positive (ER+/PR
+), (b) ER- or PR-, or unknown. Because it was not routi-
nely performed before 2000, HER2/neu was not available.
Cox proportional hazard regression was applied to
explore the relation of breast density with deaths due to
breast cancer and other causes separately as well as with
the incidence of a second breast cancer. Although mam-
mographic density is unlikely to affect all-cause mortality,
the analysis was added to show that breast density is not a
marker for high mortality. When modeling second breast
cancers, the time between first and second diagnosis was
used as the follow-up time. Because a previous analysis in
the MEC had shown that tumor stage, weight status, and
ethnicity influenced survival, these variables were consid-
ered essential covariates [22]; all three changed the hazard
ratio (HR) by more than 10%. Potential confounders - that
is, menopausal status, co-morbidity (hypertension, diabetes,
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heart disease, or stroke), hormone replacement therapy, ER
and PR status, and treatment (surgery, chemotherapy) -
were evaluated. Because the results of the log-likelihood
ratio test indicated no improvement in model fit (c2 =
6.43, 6 degrees of freedom (df), P = 0.38) and the HR for
the overall model changed less than 10% (0.95 to 0.92), we
decided not to include them. Given the previously reported
effect modification by radiotherapy [13], we modeled the
interaction between breast density and radiation by using
cross-product terms and performed stratified analyses by
radiation treatment. Owing to the limited sample size,
separate analyses by ethnicity were not possible.
Results
Japanese-Americans and Caucasians constituted the lar-
gest proportion of study participants (Table 1). Native
Hawaiians, followed by Caucasians, had the highest BMI
and the largest total breast area, whereas Japanese and
‘Others’ had the highest percent density because of their
relatively small breast sizes. Of the 607 breast cancer
cases, 125 were diagnosed as in situ, 380 as local, and 100
as advanced (regional/distant). After a mean follow-up
time of 12.9 years, 27 deaths from breast cancer and
100 deaths from other causes occurred. By category,
215 women had less than 25%, 209 women had 25% to
less than 50%, and 183 women had at least 50% breast
density (Table 2). The respective values for the 25 breast
cancer deaths were 9, 7, and 11 events.
The age at diagnosis of women with radiation was simi-
lar to that of women without radiation (63.0 versus 63.8
years; P = 0.28), and the stage distribution also did not
differ (P = 0.43). In total, 361 women received radiation
(Table 2), 57.6% of the in situ, 62.6% of local, and 59.0% of
advanced cases. In those with radiation, 11 (5.9%) breast
cancer deaths occurred in the low-density and 5 (2.9%) in
the high-density group. Among the 246 women without
Table 1 Characteristics of breast cancer cases by ethnic group
Characteristic Native Hawaiian Japanese Caucasian Other All
Number of cases 79 292 195 41 607
Number of deaths 20 51 54 2 127
Breast cancer 7 10 9 1 27
All other causes 13 41 45 1 100
Stage at diagnosis, number
In situ 10 68 38 9 125
Local 50 175 131 24 380
Advanced 19 48 25 8 100
Unknown 0 1 1 0 2
Number of second breast cancers 12 29 25 5 71
Mean age at mammograms, years 57.8 60.2 60.4 55.5 59.6
Age at diagnosis, years 61.7 63.9 63.9 59.3 63.3
Time from first mammogram to diagnosis, yearsa 6.3 6.7 6.7 6.4 6.3
Years of follow-up 12.4 13.2 12.6 13.8 12.9
Total breast area, cm2 139.4 92.0 136.7 98.0 112.9
Dense breast area, cm2 37.7 32.0 41.6 41.4 36.5
Percent density 30.1 38.2 36.2 45.1 37.0
Body mass index, kg/m2 28.2 24.3 25.2 24.4 25.1
Family history, percentageb 25.3 16.1 14.9 19.5 17.1
Age at menarche, years 12.9 12.9 13.0 13.8 13.0
Parous, percentage 87.3 84.3 82.1 80.5 83.7
At least 30 years old at first birth, percentage 3.8 10.3 8.7 14.6 9.2
Number of children 3.1 2.2 2.2 2.3 2.3
Postmenopausal, percentage 80.0 79.5 85.1 63.4 79.7
Use of any HRT, percentagec 48.1 24.3 34.9 31.7 31.3
ERT use, percentage 24.1 44.5 38.0 19.5 38.1
EPRT use, percentage 27.9 31.2 27.2 48.8 30.6
Values are presented as means unless indicated otherwise. aNumber of years from the earliest scanned mammogram to the diagnosis of breast cancer. bWomen
who have first-degree relatives with breast cancer. cPostmenopausal women are the denominator for the hormone replacement therapy (HRT) use. EPRT,
combined estrogen-progestin replacement therapy; ERT, estrogen-only replacement therapy.
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radiation, 1 (0.9%) death was observed in the low-density
group and 10 (7.8%) deaths in the high-density group.
After a mean time of 6.6 ± 4.4 years since the first diag-
nosis, 71 new breast cancer tumors were diagnosed: 56
occurred in the contralateral and 15 in the same side as
the primary tumor. Among cases with secondary tumors,
38 women had received radiation and 33 had not.
In the overall model with 607 cases, mammographic den-
sity did not predict death due to breast cancer (Table 2).
The HRs were 0.95 (95% CI 0.79 to 1.15) for percent den-
sity as a continuous variable and 0.83 (95% CI 0.36 to 1.92)
as a dichotomous variable. Compared with HRs of women
with less than 25% density, the HRs for the intermediate
and high categories were 0.60 (95% CI 0.22 to 1.66) and
0.89 (95% CI 0.34 to 2.33), respectively. However, the inter-
action between percent density and radiation therapy was
significant (P for continuous density = 0.006 and P = 0.02
for the two categorical analyses). At the same time, the risk
estimates became elevated and borderline significant. The
stratified models indicated divergent results for the two
groups. Percent density was associated with a reduced risk
of dying from breast cancer in women who had received
radiation (HR = 0.77, 95% CI 0.60 to 0.99; P = 0.04) but
with an elevated risk in patients who had not received
radiation (HR = 1.46, 95% CI 1.00 to 2.14; P = 0.05). The
results were similar when women were dichotomized by
low and high density (Figure 1) and when three density
categories were used (Table 2). Exclusion of in situ cases
Table 2 Survival and incidence of new breast cancer related to breast density
Outcome Model Label Per 10% density Percent densitya Percent density categories
Low High < 25% 25 to < 50% ≥ 50%
Breast cancer death All Number 607 304 303 215 209 183
Deaths 27 12 15 9 7 11
HRb 0.95 1 0.83 1 0.60 0.89
95% CI 0.79-1.15 0.36-1.92 0.22-1.66 0.34-2.33
P value 0.61 0.67 0.33 0.80
All plus interaction (density × radiation) Number 607 304 303 215 209 183
Deaths 27 12 15 9 7 11
HRb 1.38 1 5.31 1 0.96 2.54
95% CI 0.99-1.92 0.66-43.1 0.33-2.79 0.65-9.88
P value 0.06 0.12 0.94 0.18
With radiation Number 361 175 170 128 131 102
Deaths 16 11 5 9 2 5
HRb 0.77 1 0.33 1 0.19 0.42
95% CI 0.60-0.99 0.11-1.06 0.04-0.91 0.12-1.40
P value 0.04 0.06 0.04 0.16
Without radiation Number 246 118 128 87 78 81
Deaths 11 1 10 0 5 6
HR 1.46 1 5.57 1 1.34
95% CI 1.00-2.14 0.65-48.0 0.34-5.34
P value 0.05 0.12 0.68
Other causes of death All Number 607 304 303 215 209 183
Deaths 100 55 45 44 28 28
HRb 1.08 1.37 1.06 1.32
95% CI 0.98-1.20 0.88-2.13 0.64-1.75 0.77-2.25
P value 0.13 0.16 0.83 0.32
Second breast cancer All plus interaction (density × radiation) Number 607 304 303 215 209 183
Cases 71 32 39 22 23 26
HRb 1.13 1 1.72 1 1.31 2.11
95% CI 0.96-1.33 0.88-2.55 0.69-2.50 0.98-4.50
P value 0.14 0.15 0.41 0.06
aLow density = < 35%; high density ≥ 35%. bHazard ratios (HRs) and 95% confidence intervals (CIs) for the effect of density estimated by Cox regression with
adjustment for age at diagnosis, ethnicity, overweight/obesity, stage of disease at diagnosis (in situ, localized, or advanced), and radiation treatment when applicable.
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Figure 1 Breast cancer survival stratified by radiation treatment in participants of a nested case-control study within the Multiethnic
Cohort. Survival by mammographic density (low density = less than 35%; high density = at least 35%) was estimated by Cox regression with
adjustment for age at diagnosis, ethnicity, obesity, stage of disease at diagnosis (in situ, localized, or advanced), and radiation treatment.
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modified the HRs minimally because only one death
occurred among them. The respective HRs for all breast
cancer deaths with and without interaction using the con-
tinuous density variable were 0.92 (95% CI 0.76 to 1.12)
and 1.29 (95% CI 0.91 to 1.81); the value for cases who had
received radiation did not change and, for those without
radiation, was 1.37 (95% CI 0.93 to 2.02).
Mammographic density was not associated with death
from other causes when the continuous density variable
(HR = 1.08, 95% CI 0.98 to 1.20) or density categories
were used. However, the risk for a second breast cancer
was 70% higher in women with high density (HR = 1.72,
95% CI 0.88 to 2.55; P = 0.15) and more than doubled
when women with less than 25% were compared with
those with at least 50% density (HR = 2.11, 95% CI 0.98
to 4.50). After exclusion of the 15 primaries that occurred
in the ipsilateral breast, the risk estimates were attenu-
ated. For example, the HRs for the intermediate- and
high-density categories as compared with less than 25%
were 1.15 (95% CI 0.45 to 2.97) and 1.43 (95% CI 0.51 to
4.01), respectively. No interaction with radiation was
observed.
Discussion
This investigation among 607 breast cancer cases with
nearly 13 years of follow-up since diagnosis found an
adverse effect of high mammographic density on breast
cancer survival among patients who had not received
radiation treatment. In contrast, among patients who had
received radiation, women with dense breasts experienced
a lower risk of death from breast cancer. Mammographic
density was not associated with mortality from other
causes of death. The non-significantly higher risk for a sec-
ond primary breast cancer was attenuated after excluding
ipsilateral cases, which are more likely to be recurrences.
Also, radiotherapy did not modify the susceptibility of
breast tissue to develop a second tumor.
The interaction seen here between breast density and
radiation agrees with a report showing that women with
high breast density had a significantly elevated risk to
develop local breast cancer recurrence if they had not
received radiotherapy [13]. Among 335 women, the
respective proportions of recurrences for the low-,
intermediate-, and high-density groups were 3 out of 99,
11 out of 107, and 20 out of 129. The 10-year actuarial
risks were 21% versus 5% with an HR of 5.7 (P = 0.006)
when the high group of patients was compared with the
low-density group, but no association was seen in
patients who received radiation, a finding that disagrees
with the protective effect of radiation treatment on
breast density seen in our study. In an investigation of
136 patients who had all received radiation, local recur-
rence rates were higher when the top quartile of breast
density was compared with the lowest [14]. Women
with 75% or more mammographic density experienced a
4.3-fold higher risk of local recurrence. Also, in agree-
ment with our analysis, the risk of invasive breast cancer
was threefold higher in women with very high breast
density and a diagnosis of DCIS [12].
Despite the large number of cases, two mammography
cohorts did not detect significant effects of mammo-
graphic density on breast cancer survival [15,17], whereas
the Swedish cohort reported a borderline association of
breast density with survival (P = 0.10) [16]. The density
assessment by qualitative methods - that is, BI-RADS
(Breast Imaging-Reporting and Data System) or Tabár -
raises the question about the accuracy of the risk classifi-
cation. In comparison with studies using quantitative
methods, interobserver agreement is relatively low and
data are often provided by multiple readers. Our findings
also concur with an observation in the Nurses’ Health
Study, which found an association of more aggressive
tumor characteristics (that is, size, ER-negative, and grade)
in women with high breast density [23], and with a study
in 231 British women who demonstrated a high probabil-
ity for tumors to arise within parts of the breast that
appear dense on mammographic images [24].
However, the previous studies disagree on whether
radiotherapy modifies the association of mammographic
density with recurrence [12-14]. Whereas one study
observed an effect only in women without radiotherapy
[13], another study whose participants had all received
radiotherapy reported an increased risk [14], and a third
study found that invasive breast cancer occurred after
DCIS in women who received radiotherapy and in those
who did not [12]. One of the studies found obesity to be
a stronger predictor of local recurrence than breast den-
sity [14], but BMI was not included in the other study
[13]. This may have introduced bias given that BMI is a
negative confounder between breast density and breast
cancer risk (that is, it has an inverse association with
the former and a direct association with the latter) and
is associated with poorer breast cancer survival [25].
None of the three mammography cohorts that examined
breast cancer survival explored effect modification by
radiotherapy [15-17].
The mechanisms underlying the paradoxical lower risk
of mortality associated with the joint effects of high
breast density and radiotherapy are unclear. Clinical trials
have shown that chemotherapy and hormonal treatment
have a higher impact on breast cancer survival but that
treatment with breast-conserving surgery plus radiation
has survival rates similar to those of mastectomy but
higher local recurrence rates [26]. Therefore, our findings
are more likely to be due to local disease recurrence and
its after-effects [27] or a result of the so-called field effect
(that is, the presence of cancer-like signatures in histolo-
gically normal tissues surrounding the primary tumor
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[28]). Adjuvant radiotherapy may favorably alter the
tumor microenvironment and ECM to prevent recur-
rence [29-31]. It is possible that the collagen-dense
stroma associated with mammographic density enhances
the effectiveness of radiotherapy in preventing residual
neoplastic cell growth and invasion. For example, the
stromal matrix regulatory protein tissue metalloprotei-
nase-3 (MMP-3) has been positively associated with
mammographic density [5]; MMP-3 may play a critical
role in the progression of residual neoplastic cells.
Recently, MMP inhibitor-targeted treatment, in combina-
tion with radiotherapy, has been proposed as a strategy to
improve breast cancer survival [32]. Furthermore, breast
density has been associated with tumor growth factor-b
activity [33], a potentially important mediator of the
microenvironment’s response to radiotherapy [29].
Unfortunately, we cannot determine whether the excess
breast cancer mortality in cases without radiation was
due to local or distant recurrence.
The major limitations of this study are the small number
of deaths and the lack of recurrence information. The out-
comes are based on data from a SEER registry, which does
not routinely collect recurrence. However, the treatment
data obtained directly from the HTR are considered of
good quality because of the limited number of such facil-
ities in the State of Hawaii and the low likelihood of
receiving treatment out of state. Only 9 out of the 607
(1.5%) cases had a code indicating uncertainty about radia-
tion treatment received. Strengths of our analysis are the
availability of repeated mammograms, the long follow-up
time, and the high quality of the mammographic density
assessment method that provided quantitative estimates
rather than qualitative categories.
Conclusions
This longitudinal investigation with 13 years of follow-up
found an adverse effect of high mammographic density on
breast cancer survival among patients who had not
received radiation treatment and a lower risk of death
from breast cancer in women who had received radiation.
To confirm the findings of this exploratory analysis, it
appears feasible to reanalyze large breast cancer clinical
trials for differences in outcomes according to breast den-
sity. Although chemotherapy was not significant in our
study, effect modification with other treatment modalities
could also be investigated, but there are biologic reasons
to think that radiotherapy has a more pronounced effect
on stroma, and, in particular, the ECMs that constitute
mammographic density, than on breasts with a high pro-
portion of fat tissue. Assessing mammographic density in
women with breast cancer may help to identify women
with a poorer prognosis. The implications of this research
may be important for future treatment of breast cancer in
women with high breast density who may benefit from
additional radiotherapy.
Abbreviations
BMI: body mass index; CI: confidence interval; DCIS: ductal carcinoma in situ;
ECM: extracellular matrix; ER: estrogen receptor; HR: hazard ratio; HTR: Hawaii
Tumor Registry; MEC: Multiethnic Cohort; MMP-3: metalloproteinase-3; PR:
progesterone receptor; SEER: Surveillance, Epidemiology, and End Results.
Authors’ contributions
All authors made substantial contributions to conception and design,
analysis and interpretation of data, and critical review of the manuscript. GM
conceived of the study, coordinated the data acquisition and analysis, and
helped to draft the manuscript. ISP participated in planning the statistical
methods and performed part of the analysis. ML helped to draft the
manuscript. SMC contributed to the data analysis and drafted parts of the
manuscript. LNK and SYP participated in the design of the study and in the
statistical analysis. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
This case-control study was funded by a grant from the National Cancer
Institute (R01 CA85265). The Multiethnic Cohort Study has been supported
by US Public Health Service (National Cancer Institute) grant R37 CA54281
(principal investigator: LNK). The Hawaii Tumor Registry is supported by
Contract N01-261201000037C-3-0-1. ML was supported during the work on
this project by a postdoctoral fellowship on grant R25 CA90956. The funding
bodies had no role in the design; in the collection, analysis, or interpretation
of data; in the writing of the manuscript; or in the decision to submit the
manuscript for publication.
Author details
1University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI 96813,
USA. 2Canada Department of Population Health Research, Alberta Health
Services-Cancer Care, Box ACB 2210-2nd Street SW, Calgary, AB, T2S 3C3,
Canada.
Received: 10 September 2012 Revised: 8 January 2013
Accepted: 17 January 2013 Published: 22 January 2013
References
1. McCormack VA, dos Santos Silva I: Breast density and parenchymal
patterns as markers of breast cancer risk: a meta-analysis. Cancer
Epidemiol Biomarkers Prev 2006, 15:1159-1169.
2. Tot T, Tabar L, Dean PB: The pressing need for better histologic-
mammographic correlation of the many variations in normal breast
anatomy. Virchows Arch 2000, 437:338-344.
3. Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R,
Martin L, Boyd N: The association of measured breast tissue
characteristics with mammographic density and other risk factors for
breast cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:343-349.
4. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH: Mammographic
density is related to stroma and stromal proteoglycan expression. Breast
Cancer Res 2003, 5:R129-R135.
5. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF:
Growth factors and stromal matrix proteins associated with
mammographic densities. Cancer Epidemiol Biomarkers Prev 2001, 10:243-248.
6. Boyd NF, Jensen HM, Cooke G, Han HL: Relationship between
mammographic and histological risk factors for breast cancer. J Natl
Cancer Inst 1992, 84:1170-1179.
7. Ghajar CM, Bissell MJ: Extracellular matrix control of mammary gland
morphogenesis and tumorigenesis: insights from imaging. Histochem Cell
Biol 2008, 130:1105-1118.
8. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT,
White JG, Keely PJ: Collagen density promotes mammary tumor initiation
and progression. BMC Med 2008, 6:11.
Maskarinec et al. Breast Cancer Research 2013, 15:R7
http://breast-cancer-research.com/content/15/1/R7
Page 7 of 8
9. Butcher DT, Alliston T, Weaver VM: A tense situation: forcing tumour
progression. Nat Rev Cancer 2009, 9:108-122.
10. Barcellos-Hoff MH, Medina D: New highlights on stroma-epithelial
interactions in breast cancer. Breast Cancer Res 2005, 7:33-36.
11. Hawes D, Downey S, Pearce CL, Bartow S, Wan P, Pike MC, Wu AH: Dense
breast stromal tissue shows greatly increased concentration of breast
epithelium but no increase in its proliferative activity. Breast Cancer Res
2006, 8:R24.
12. Habel LA, Dignam JJ, Land SR, Salane M, Capra AM, Julian TB:
Mammographic density and breast cancer after ductal carcinoma in situ.
J Natl Cancer Inst 2004, 96:1467-1472.
13. Cil T, Fishell E, Hanna W, Sun P, Rawlinson E, Narod SA, McCready DR:
Mammographic density and the risk of breast cancer recurrence after
breast-conserving surgery. Cancer 2009, 115:5780-5787.
14. Park CC, Rembert J, Chew K, Moore D, Kerlikowske K: High mammographic
breast density is independent predictor of local but not distant
recurrence after lumpectomy and radiotherapy for invasive breast
cancer. Int J Radiat Oncol Biol Phys 2009, 73:75-79.
15. Porter GJ, Evans AJ, Cornford EJ, Burrell HC, James JJ, Lee AH, Chakrabarti J:
Influence of mammographic parenchymal pattern in screening-detected
and interval invasive breast cancers on pathologic features,
mammographic features, and patient survival. AJR Am J Roentgenol 2007,
188:676-683.
16. Chiu SY, Duffy S, Yen AM, Tabar L, Smith RA, Chen HH: Effect of baseline
breast density on breast cancer incidence, stage, mortality, and
screening parameters: 25-year follow-up of a Swedish mammographic
screening. Cancer Epidemiol Biomarkers Prev 2010, 19:1219-1228.
17. Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM,
Weaver DL, Schairer C, Taplin SH, Sherman ME: Relationship between
mammographic density and breast cancer death in the breast cancer
surveillance consortium. J Natl Cancer Inst 2012, 104:1218-1227.
18. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN: Mammographic
density and breast cancer risk: the multiethnic cohort study. Am J
Epidemiol 2005, 162:743-752.
19. Kolonel LN, Henderson BE, Hankin JH, Nomura AMY, Wilkens LR, Pike MC,
Stram DO, Monroe KR, Earle ME, Nagamine FS: A multiethnic cohort in
Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000,
151:346-357.
20. National Cancer Institute, Surveillance, Epidemiology and End Results
Program: 2007 Multiple primary coding and histology rules. [http://seer.
cancer.gov/tools/mphrules/].
21. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative analysis
of mammographic densities. Phys Med Biol 1994, 39:1629-1638.
22. Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE, Kolonel LN:
Obesity and breast cancer survival in ethnically diverse postmenopausal
women: the Multiethnic Cohort Study. Breast Cancer Res Treat 2011,
129:565-574.
23. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C,
Tamimi RM: Mammographic breast density and subsequent risk of breast
cancer in postmenopausal women according to tumor characteristics.
J Natl Cancer Inst 2011, 103:1179-1189.
24. Pinto Pereira SM, McCormack VA, Hipwell JH, Record C, Wilkinson LS,
Moss SM, Hawkes DJ, dos-Santos-Silva I: Localized fibroglandular tissue as
a predictor of future tumor location within the breast. Cancer Epidemiol
Biomarkers Prev 2011, 20:1718-1725.
25. Patterson RE, Cadmus LA, Emond JA, Pierce JP: Physical activity, diet,
adiposity and female breast cancer prognosis: a review of the
epidemiologic literature. Maturitas 2010, 66:5-15.
26. Halyard MY, Wasif N, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L,
Goyal S, Horst KC, Moran MS, MacDonald SM, Haffty BG: ACR
Appropriateness Criteria(R) local-regional recurrence (LR) and salvage
surgery: breast cancer. Am J Clin Oncol 2012, 35:178-182.
27. Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S,
McGale P, Taylor C, Wang YC, Bergh J, Di LA, Albain K, Swain S, Piccart M,
Pritchard K: Comparisons between different polychemotherapy regimens
for early breast cancer: meta-analyses of long-term outcome among
100,000 women in 123 randomised trials. Lancet 2012, 379:432-444.
28. Heaphy CM, Griffith JK, Bisoffi M: Mammary field cancerization: molecular
evidence and clinical importance. Breast Cancer Res Treat 2009, 118:229-239.
29. Barcellos-Hoff MH, Park C, Wright EG: Radiation and the microenvironment
- tumorigenesis and therapy. Nat Rev Cancer 2005, 5:867-875.
30. Formenti SC, Demaria S: Local control by radiotherapy: is that all there is?
Breast Cancer Res 2008, 10:215.
31. Haveman J, Rodermond H, van Bree C, Wondergem J, Franken NA:
Residual late radiation damage in mouse stromal tissue assessed by the
tumor bed effect. J Radiat Res 2007, 48:107-112.
32. Artacho-Cordon F, Rios-Arrabal S, Lara PC, Artacho-Cordon A, Calvente I,
Nunez MI: Matrix metalloproteinases: potential therapy to prevent the
development of second malignancies after breast radiotherapy. Surg
Oncol 2012, 21:e143-e151.
33. Yang WT, Lewis MT, Hess K, Wong H, Tsimelzon A, Karadag N, Cairo M,
Wei C, Meric-Bernstam F, Brown P, Arun B, Hortobagyi GN, Sahin A,
Chang JC: Decreased TGFbeta signaling and increased COX2 expression
in high risk women with increased mammographic breast density. Breast
Cancer Res Treat 2010, 119:305-314.
doi:10.1186/bcr3378
Cite this article as: Maskarinec et al.: Mammographic density as a
predictor of breast cancer survival: the Multiethnic Cohort. Breast Cancer
Research 2013 15:R7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Maskarinec et al. Breast Cancer Research 2013, 15:R7
http://breast-cancer-research.com/content/15/1/R7
Page 8 of 8
